2024-519180-17-00RecruitingPhase 1
A PHASE 1 STUDY WITH SINGLE ASCENDING DOSE, MULTIPLE ASCENDING DOSE AND FOOD EFFECT OF LMT503 IN HEALTHY SUBJECTS.
Lmito Therapeutics Inc.1 site in 1 country72 target enrollmentStarted: November 25, 2024Last updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Lmito Therapeutics Inc.
- Enrollment
- 72
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Eunju Lee
Scientific
Lmito Therapeutics Inc.
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of SZN-043, a Novel Bispecific Fusion Protein Targeting ASGR1 and ZNRF3/RNF43, in Healthy Volunteers and Subjects with Liver CirrhosisAlcoholic HepatitisInflammatory and Immune System - Other inflammatory or immune system disordersLiver CirrhosisACTRN12622000392763Surrozen Operating, Inc.40
Recruiting
Phase 1
A phase I study of epinephrine sublingual tablet in healthy subjectsCTRI/2020/09/027808Belcher Pharmaceuticals
Not yet recruiting
Phase 1
SAD, Phase I Trial to Assess Safety, Tolerability and PK Profile of MSP008-22in Patients With Advanced Solid TumoursCTRI/2022/06/043504Godavari Biorefineries Limited
Completed
Phase 1
Phase I Single- and Multiple-Ascending Dose Trial of EVX-101Mental and Behavioural DisordersDepressionISRCTN42835524Evecxia Therapeutics Inc.38
Completed
Not Applicable
Evaluation of biomarkers for JAK inhibitorKCT0005706Seoul National University Hospital8